BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/15/2018 12:09:30 PM | Browse: 945 | Download: 2202
 |
Received |
|
2018-06-02 03:46 |
|
Peer-Review Started |
|
2018-06-02 11:19 |
|
First Decision by Editorial Office Director |
|
2018-07-09 01:13 |
|
Return for Revision |
|
2018-07-10 08:55 |
|
Revised |
|
2018-07-17 01:58 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2018-08-22 08:29 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2018-08-26 18:18 |
|
Articles in Press |
|
2018-08-26 18:18 |
|
Edit the Manuscript by Language Editor |
|
2018-09-10 17:56 |
|
Typeset the Manuscript |
|
2018-10-14 11:36 |
|
Publish the Manuscript Online |
|
2018-10-15 12:09 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Prognostic value of vascular endothelial growth factor receptor 1 and class III β-tubulin in survival for non-metastatic rectal cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xiang-Quan Kong, Yun-Xia Huang, Jin-Luan Li, Xue-Qing Zhang, Qing-Qin Peng, Li-Rui Tang and Jun-Xin Wu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Fujian Province Natural Science Foundation |
2016J01437 |
|
2017J01260 |
|
2018J01266 |
| Fujian Medical Innovation Project |
2015-CX-8 |
| Peking University Cancer Hospital and Institute, Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education/Beijing (2017 Open Project-9), Joint Funds for the innovation of science and Technology, Fujian Province |
2017Y9074 |
|
| Corresponding Author |
Jun-Xin Wu, PhD, Attending Doctor, Professor, Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, 420 Fuma Rd, Jinan District, Fuzhou 350014, Fujian Province, China. junxinwufj@aliyun.com |
| Key Words |
Rectal cancer; Class Ⅲ β-tubulin; Vascular endothelial growth factor receptor 1; Overall survival |
| Core Tip |
Nowadays, personalized and precision medicine becomes vital in cancer treatment. Herein, we focus on the long-term prognostic value of vascular endothelial growth factor receptor 1 (VEGFR1) and class Ⅲ β-tubulin (TUBB3) mRNA expression in non-metastatic rectal cancer. In the 75 consecutive patients enrolled, we found that VEGFR1 expression and lymph node metastasis were independent factors influencing overall survival, and the combination of them showed a favorable prognostic value. Also, VEGFR1 expression was significantly related to lymph node metastasis. In addition, VEGFR1 expression was positively correlated with TUBB3 expression. |
| Publish Date |
2018-10-15 12:09 |
| Citation |
Kong XQ, Huang YX, Li JL, Zhang XQ, Peng QQ, Tang LR, Wu JX. Prognostic value of vascular endothelial growth factor receptor 1 and class III β-tubulin in survival for non-metastatic rectal cancer. World J Gastrointest Oncol 2018; 10(10): 351-359 |
| URL |
http://www.wjgnet.com/1948-5204/full/v10/i10/351.htm |
| DOI |
http://dx.doi.org/10.4251/wjgo.v10.i10.351 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
